Summary unavailable.

Questions

Question 1

Which anticholinergic agent is specifically listed for the management of Parkinson's disease?

View answer and explanation
Question 2

What is the primary mechanism of action for anticholinergic agents?

View answer and explanation
Question 3

The use of anticholinergics is contraindicated in patients with which of the following eye conditions?

View answer and explanation
Question 4

Which substance may decrease the absorption of orally administered anticholinergics?

View answer and explanation
Question 5

How long before travel should a scopolamine transdermal patch be applied?

View answer and explanation
Question 6

What advice should be given to a patient taking anticholinergics who experiences dry mouth?

View answer and explanation
Question 7

Which two anticholinergic agents are listed for use as ophthalmic mydriatics?

View answer and explanation
Question 8

Which patient populations are noted to be more susceptible to the adverse effects of anticholinergics?

View answer and explanation
Question 9

Additive anticholinergic effects, such as dry mouth and blurred vision, can occur when these agents are used with which other class of drugs?

View answer and explanation
Question 10

Which of the following is a desired outcome for a patient taking an anticholinergic for motion sickness?

View answer and explanation
Question 11

For which conditions is ipratropium primarily used as an anticholinergic agent?

View answer and explanation
Question 12

Atropine, glycopyrrolate, propantheline, and scopolamine are specifically classified as antimuscarinic because they inhibit acetylcholine at which sites?

View answer and explanation
Question 13

Anticholinergics are contraindicated in patients with tachycardia that is due to thyrotoxicosis or what other condition?

View answer and explanation
Question 14

When should oral doses of glycopyrrolate, propantheline, or scopolamine be administered in relation to meals?

View answer and explanation
Question 15

What visual side effect should a patient be warned about when using ophthalmic anticholinergic preparations?

View answer and explanation
Question 16

Which anticholinergic agent is indicated for the treatment of bradyarrhythmias?

View answer and explanation
Question 17

How might anticholinergics affect the gastrointestinal (GI) absorption of other drugs?

View answer and explanation
Question 18

During IV drug therapy with anticholinergics, what should a nurse monitor frequently?

View answer and explanation
Question 19

Impaired oral mucous membrane is listed as a potential nursing diagnosis related to which aspect of anticholinergic therapy?

View answer and explanation
Question 20

A successful outcome for a patient with Parkinson's disease taking an anticholinergic would be the resolution of what?

View answer and explanation
Question 21

Oxybutynin and tolterodine are anticholinergic agents used for what purpose?

View answer and explanation
Question 22

Besides hypersensitivity and narrow-angle glaucoma, anticholinergics are also contraindicated in patients with which neuromuscular disorder?

View answer and explanation
Question 23

Caution should be exercised when using anticholinergics in patients with chronic renal, hepatic, cardiac, or which other organ system disease?

View answer and explanation
Question 24

Co-administration of anticholinergics with antidepressants, quinidine, and disopyramide can lead to what type of effects?

View answer and explanation
Question 25

Why is it important for a nurse to monitor intake and output ratios in elderly or surgical patients taking anticholinergics?

View answer and explanation
Question 26

Due to the risk of drowsiness, patients taking anticholinergics should be cautioned to avoid what activity?

View answer and explanation
Question 27

Propantheline and glycopyrrolate are used to decrease gastric secretory activity and increase the tone of what structure?

View answer and explanation
Question 28

The term 'antimuscarinic' refers to the inhibition of acetylcholine's action at what specific type of nerve fiber?

View answer and explanation
Question 29

Anticholinergics are contraindicated in patients with tachycardia that is due to thyrotoxicosis or cardiac insufficiency. What other condition is also a contraindication?

View answer and explanation
Question 30

Caution is advised when prescribing anticholinergics to patients at risk for obstruction of which body system?

View answer and explanation
Question 31

A nurse should assess a patient on anticholinergics for abdominal distention and auscultate for bowel sounds because of the risk of what side effect?

View answer and explanation
Question 32

One of the desired outcomes of anticholinergic therapy, particularly when used for ophthalmic purposes, is what change in the pupils?

View answer and explanation
Question 33

Scopolamine is an anticholinergic used to treat nausea and vomiting related to vertigo and what other condition?

View answer and explanation
Question 34

What recommendation is given to patients using ophthalmic anticholinergic preparations to manage photosensitivity?

View answer and explanation
Question 35

Anticholinergic drugs inhibit GI motility, which can lead to an increase in what factor for other orally administered drugs?

View answer and explanation
Question 36

Constipation is listed as a potential nursing diagnosis for patients taking anticholinergics and is categorized under what?

View answer and explanation
Question 37

For a patient receiving Atropine for bradycardia, what is the primary desired outcome related to heart rate?

View answer and explanation
Question 38

What is the general physiological effect of anticholinergics by competitively inhibiting acetylcholine?

View answer and explanation
Question 39

When assessing a patient on IV anticholinergic therapy, a nurse should report any significant increase in ventricular ectopy or what other cardiac symptom?

View answer and explanation
Question 40

The transdermal patch form of which anticholinergic is used for preventing motion sickness?

View answer and explanation
Question 41

Cautionary use of anticholinergics is recommended for patients with urinary tract pathology due to the potential for what adverse effect?

View answer and explanation
Question 42

Which of the following is NOT an expected additive anticholinergic effect when these drugs are combined with others like antihistamines?

View answer and explanation
Question 43

Besides increased heart rate and dilation of pupils, what is another desired outcome related to GI motility from anticholinergic use?

View answer and explanation
Question 44

Atropine is used for bradyarrhythmias, and ipratropium is used for bronchospasm. What is the listed use for benztropine?

View answer and explanation
Question 45

What term describes the general class of nerve fibers where antimuscarinics like atropine exert their inhibitory effects?

View answer and explanation
Question 46

Decreased cardiac output is a potential nursing diagnosis for patients on anticholinergics and is related to what aspect of the drug's use?

View answer and explanation
Question 47

When managing dry mouth from anticholinergics, what is a key element of the recommended oral hygiene?

View answer and explanation
Question 48

Why is it important to auscultate for bowel sounds in a patient taking anticholinergics?

View answer and explanation
Question 49

Anticholinergics function by inhibiting which neurotransmitter?

View answer and explanation
Question 50

Oral anticholinergics like glycopyrrolate are administered 30 minutes before meals. When should the scopolamine patch be applied for travel?

View answer and explanation

Other chapters

HOW TO USE DAVIS'S DRUG GUIDE FOR NURSESEVIDENCE-BASED PRACTICE AND PHARMACOTHERAPEUTICS: Implications for NursesPHARMACOGENOMICSMEDICATION ERRORS: Improving Practices and Patient SafetyDETECTING AND MANAGING ADVERSE DRUG REACTIONSOVERVIEW OF RISK EVALUATION AND MITIGATION SYSTEMS (REMS)SPECIAL DOSING CONSIDERATIONSTHE CYTOCHROME P450 SYSTEMEDUCATING PATIENTS ABOUT SAFE MEDICATION USEAnti-Alzheimer's agentsAntianemicsAntianginalsAntianxiety agentsAntiarrhythmicsAntiasthmaticsAnticoagulantsAnticonvulsantsAntidepressantsAntidiabeticsAntidiarrhealsAntiemeticsAntifungalsAntihistaminesAntihypertensivesAnti-infectivesAntineoplasticsAntiparkinson agentsAntiplatelet agentsAntipsychoticsAntipyreticsAntirheumaticsAntiulcer agentsAntiviralsBeta blockersBone resorption inhibitorsBronchodilatorsCalcium channel blockersCentral nervous system stimulantsCorticosteroidsDiureticsHormonesImmunosuppressantsLaxativesLipid lowering agentsMinerals/electrolytes/pH modifiersNonopioid analgesicsNonsteroidal anti-inflammatory agentsOpioid analgesicsSedative/hypnoticsSkeletal muscle relaxantsThrombolyticsVaccines/immunizing agentsVitaminsDRUGS APPROVED IN CANADANATURAL/HERBAL PRODUCTSMEDICATION SAFETY TOOLSAppendix A. Recent Drug ApprovalsAppendix E. Administering Medications to ChildrenAppendix G. Pediatric Dosage CalculationsAppendix I. Controlled Substance SchedulesAppendix L. Insulins and Insulin TherapyAppendix M. Canadian and U.S. Pharmaceutical PracticesAppendix N. Routine Pediatric and Adult Immunizations